News - Syntaxin

Filter

Current filters:

Syntaxin

Popular Filters

Syntaxin and Ipsen in up to $99 million collaboration on novel botulinum-toxin therapeutics

21-10-2011

French drugmaker Ipsen (Euronext: IPN) has entered into a global strategic collaboration with privately-held…

BiotechnologyIpsenLicensingPharmaceuticalResearchSyntaxin

Company Spotlight

Fibrotech

Fibrotech

Back to top